Announcements and Notices - [Other - Business Update]

Lifetech Scientific Corporation develops, manufactures and markets minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders.  The Company produces congenital heart defect occluders, vena cava filters, stent grafts, balloon catheters, and vascular plugs.

Voluntary Announcement - Publication Of The One-Year Follow-Up Results Of Phase Iii Clinical Study Of Ibs Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

Notification Letter And Request Form To Non-Registered Shareholders

Notification Letter And Reply Form To Registered Shareholders

Financial Statements/ESG Information - [Interim/Half-Year Report]

Interim Report 2024

Announcements and Notices - [Interim Results]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lifetech Scientific (1302 HK)

Voluntary Announcement - Publication Of The One-Year Follow-Up Results Of Phase Iii Clinical Study Of Ibs Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

Notification Letter And Request Form To Non-Registered Shareholders

Notification Letter And Reply Form To Registered Shareholders

Interim Report 2024

Interim Results Announcement For The Six Months Ended 30 June 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)